$13.05
0[0.00%]
At close: Apr 22
$13.05
0[0.00%]
PreMarket: 4:00PM EDT
Phibro Animal Health
(NASDAQ:PAHC)Phibro Animal Health Stock (NASDAQ:PAHC), Analyst Ratings, Price Targets, Predictions
Phibro Animal Health Corp has a consensus price target of $18.8, established from looking at the 16 latest analyst ratings. The last 3 analyst ratings were released from Morgan Stanley, Roth MKM, and Morgan Stanley on November 9, 2023, September 1, 2023, and August 31, 2023. With an average price target of $18 between Morgan Stanley, Roth MKM, and Morgan Stanley, there's an implied 37.93% upside for Phibro Animal Health Corp from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Morgan Stanley
Roth MKM
Roth Capital
Barclays
Morgan Stanley
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Phibro Animal Health
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/09/2023 | PAHC | Buy Now | Phibro Animal Health | $13.05 | 22.61% | Morgan Stanley | Erin Wright | $17 → $16 | Maintains | Equal-Weight | Get Alert |
| 09/01/2023 | PAHC | Buy Now | Phibro Animal Health | $13.05 | 60.92% | Roth MKM | Brian Wright | → $21 | Reiterates | Buy → Buy | Get Alert |
| 08/31/2023 | PAHC | Buy Now | Phibro Animal Health | $13.05 | 30.27% | Morgan Stanley | Erin Wright | $18 → $17 | Maintains | Equal-Weight | Get Alert |
| 08/29/2023 | PAHC | Buy Now | Phibro Animal Health | $13.05 | 60.92% | Roth MKM | Brian Wright | → $21 | Reiterates | Buy → Buy | Get Alert |
| 07/27/2023 | PAHC | Buy Now | Phibro Animal Health | $13.05 | 37.93% | Morgan Stanley | Erin Wright | $18 → $18 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 05/04/2023 | PAHC | Buy Now | Phibro Animal Health | $13.05 | 37.93% | Morgan Stanley | Erin Wright | $19 → $18 | Maintains | Equal-Weight | Get Alert |
| 02/09/2023 | PAHC | Buy Now | Phibro Animal Health | $13.05 | 45.59% | Morgan Stanley | Erin Wright | $20 → $19 | Maintains | Equal-Weight | Get Alert |
| 12/21/2022 | PAHC | Buy Now | Phibro Animal Health | $13.05 | 37.93% | Roth Capital | Brian Wright | → $18 | Initiates | → Buy | Get Alert |
| 11/10/2022 | PAHC | Buy Now | Phibro Animal Health | $13.05 | 53.26% | Morgan Stanley | Erin Wright | $21 → $20 | Maintains | Equal-Weight | Get Alert |
| 09/16/2022 | PAHC | Buy Now | Phibro Animal Health | $13.05 | 30.27% | Barclays | Balaji Prasad | $22 → $17 | Maintains | Underweight | Get Alert |
| 08/26/2022 | PAHC | Buy Now | Phibro Animal Health | $13.05 | 60.92% | Morgan Stanley | Erin Wright | $23 → $21 | Maintains | Equal-Weight | Get Alert |
| 07/25/2022 | PAHC | Buy Now | Phibro Animal Health | $13.05 | 68.58% | Barclays | Balaji Prasad | → $22 | Downgrade | Equal-Weight → Underweight | Get Alert |
| 01/10/2022 | PAHC | Buy Now | Phibro Animal Health | $13.05 | 76.25% | Barclays | Balaji Prasad | → $23 | Upgrade | Underweight → Equal-Weight | Get Alert |
| 11/18/2021 | PAHC | Buy Now | Phibro Animal Health | $13.05 | 76.25% | Morgan Stanley | Erin Wright | — | Initiates | → Equal-Weight | Get Alert |
| 07/07/2021 | PAHC | Buy Now | Phibro Animal Health | $13.05 | 76.25% | Barclays | Balaji Prasad | — | Downgrade | Equal-Weight → Underweight | Get Alert |
| 05/13/2021 | PAHC | Buy Now | Phibro Animal Health | $13.05 | 68.58% | Morgan Stanley | — | — | Maintains | Underweight | Get Alert |
FAQ
What is the target price for Phibro Animal Health (PAHC)?
The latest price target for Phibro Animal Health (NASDAQ: PAHC) was reported by Morgan Stanley on November 9, 2023. The analyst firm set a price target for $16.00 expecting PAHC to rise to within 12 months (a possible 22.61% upside). 6 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Phibro Animal Health (PAHC)?
The latest analyst rating for Phibro Animal Health (NASDAQ: PAHC) was provided by Morgan Stanley, and Phibro Animal Health maintained their equal-weight rating.
When was the last upgrade for Phibro Animal Health (PAHC)?
The last upgrade for Phibro Animal Health Corp happened on January 10, 2022 when Barclays raised their price target to $23. Barclays previously had an underweight for Phibro Animal Health Corp.
When was the last downgrade for Phibro Animal Health (PAHC)?
The last downgrade for Phibro Animal Health Corp happened on July 25, 2022 when Barclays changed their price target from N/A to $22 for Phibro Animal Health Corp.
When is the next analyst rating going to be posted or updated for Phibro Animal Health (PAHC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Phibro Animal Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Phibro Animal Health was filed on November 9, 2023 so you should expect the next rating to be made available sometime around November 9, 2024.
Is the Analyst Rating Phibro Animal Health (PAHC) correct?
While ratings are subjective and will change, the latest Phibro Animal Health (PAHC) rating was a maintained with a price target of $17.00 to $16.00. The current price Phibro Animal Health (PAHC) is trading at is $13.05, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.